Research progress of ferroptosis regulating lipid peroxidation and metabolism in occurrence and development of primary liver cancer

被引:1
作者
Shu, Yu-Jie [1 ]
Lao, Bo [1 ]
Qiu, Ying-Yang [2 ]
机构
[1] Yinzhou Dist Second Hosp, Dept Gastroenterol, 1 Qianhe Rd, Ningbo 315199, Zhejiang, Peoples R China
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 119077, Singapore
关键词
Ferroptosis; Lipid peroxidation; Primary liver cancer; Lipid metabolism; Review; SORAFENIB-INDUCED FERROPTOSIS; HEPATOCELLULAR-CARCINOMA; EMERGING ROLE; PATHWAY; AUTOPHAGY; SLC7A11; MECHANISM; PROTECTS; THERAPY; CELLS;
D O I
10.4251/wjgo.v16.i6.2335
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As a highly aggressive tumor, the pathophysiological mechanism of primary liver cancer has attracted much attention. In recent years, factors such as ferroptosis regulation, lipid peroxidation and metabolic abnormalities have emerged in the study of liver cancer, providing a new perspective for understanding the development of liver cancer. Ferroptosis regulation, lipid peroxidation and metabolic abnormalities play important roles in the occurrence and development of liver cancer. The regulation of ferroptosis is involved in apoptosis and necrosis, affecting cell survival and death. Lipid peroxidation promotes oxidative damage and promotes the invasion of liver cancer cells. Metabolic abnormalities, especially the disorders of glucose and lipid metabolism, directly affect the proliferation and growth of liver cancer cells. Studies of ferroptosis regulation and lipid peroxidation may help to discover new therapeutic targets and improve therapeutic outcomes. The understanding of metabolic abnormalities can provide new ideas for the prevention of liver cancer, and reduce the risk of disease by adjusting the metabolic process. This review focuses on the key roles of ferroptosis regulation, lipid peroxidation and metabolic abnormalities in this process.
引用
收藏
页码:2335 / 2349
页数:16
相关论文
共 110 条
  • [61] GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis
    Wang, Qiujie
    Bin, Cheng
    Xue, Qiang
    Gao, Qingzhu
    Huang, Ailong
    Wang, Kai
    Tang, Ni
    [J]. CELL DEATH & DISEASE, 2021, 12 (05)
  • [62] Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer
    Wang, Weikai
    Lu, Kaizhong
    Jiang, Xin
    Wei, Qi
    Zhu, Liyuan
    Wang, Xian
    Jin, Hongchuan
    Feng, Lifeng
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [63] Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment
    Wang, Wenwen
    Zhang, Jingjing
    Wang, Yuqing
    Xu, Yasi
    Zhang, Shirong
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 3322 - 3335
  • [64] HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression
    Wang, Yufei
    Zhao, Man
    Zhao, Lina
    Geng, Yu
    Li, Guanghao
    Chen, Lin
    Yu, Jingxuan
    Yuan, Hongfeng
    Zhang, Huihui
    Yun, Haolin
    Yuan, Ying
    Wang, Guowen
    Feng, Jinyan
    Xu, Liang
    Wang, Shuai
    Hou, Chunyu
    Yang, Guang
    Zhang, Ningning
    Lu, Wei
    Zhang, Xiaodong
    [J]. CANCER RESEARCH, 2023, 83 (07) : 1048 - 1061
  • [65] Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response-induced upregulation of CHAC1 expression
    Wang, Zhiwei
    Li, Mingxing
    Liu, Yuanfeng
    Qiao, Zhentao
    Bai, Tao
    Yang, Ling
    Liu, Bo
    [J]. ONCOLOGY REPORTS, 2021, 46 (05)
  • [66] Ferroptosis in liver disease: new insights into disease mechanisms
    Wu, Jing
    Wang, Yi
    Jiang, Rongtao
    Xue, Ran
    Yin, Xuehong
    Wu, Muchen
    Meng, Qinghua
    [J]. CELL DEATH DISCOVERY, 2021, 7 (01)
  • [67] NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score
    Wu, Liusheng
    Chen, Xiaofan
    Zeng, Qi
    Lai, Zelin
    Fan, Zhengyang
    Ruan, Xin
    Li, Xiaoqiang
    Yan, Jun
    [J]. HELIYON, 2024, 10 (07)
  • [68] Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
    Wu, Liusheng
    Li, Xiaoqiang
    Qian, Xinye
    Wang, Shuang
    Liu, Jixian
    Yan, Jun
    [J]. VACCINES, 2024, 12 (02)
  • [69] Research progress of 3D-bioprinted functional pancreas and in vitro tumor models
    Wu, Liusheng
    Li, Huansong
    Liu, Yangsui
    Fan, Zhengyang
    Xu, Jingyi
    Li, Ning
    Qian, Xinye
    Lin, Zewei
    Li, Xiaoqiang
    Yan, Jun
    [J]. INTERNATIONAL JOURNAL OF BIOPRINTING, 2024, 10 (01) : 124 - 142
  • [70] Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD)
    Wu, Liusheng
    Liu, Qi
    Ruan, Xin
    Luan, Xinyu
    Zhong, Yanfeng
    Liu, Jixian
    Yan, Jun
    Li, Xiaoqiang
    [J]. BIOMEDICINES, 2023, 11 (07)